Legal Action Alert: Allarity Therapeutics Faces Class Action Lawsuit
LOS ANGELES, Oct. 23, 2024 /PRNewswire/ — The Schall Law Firm, a well-known shareholder rights litigation firm, has announced a class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or “the Company”) ALLR. This lawsuit is based on alleged violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 set by the U.S. Securities and Exchange Commission.
Investors who bought the Company’s securities between May 17, 2022, and July 19, 2024 (the “Class Period”) should reach out to the firm by November 12, 2024.
If you are a shareholder who has experienced a financial loss, click here to participate.
We urge you to contact Brian Schall at The Schall Law Firm, located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, by calling 310-301-3335 for a free discussion about your rights. You can also visit our website at www.schallfirm.com or email us at bschall@schallfirm.com.
Please note that the class has yet to be certified; until that happens, any investors taking no action will remain absent class members.
The Complaint states that the Company made false and misleading statements regarding its operations. Additionally, Allarity and its leaders allegedly engaged in improper conduct related to the Dovitinib NDA and/or the Dovitinib-DRP PMA. These actions raised the risk of regulatory scrutiny against the Company. Furthermore, Allarity allegedly minimized the chances of enforcement action in light of an announced investigation. Consequently, the public statements made by the Company were deemed to be false and materially misleading throughout the class period. When the truth was revealed, investors faced significant losses.
Join the case to seek recovery for your losses.
The Schall Law Firm has a global reputation in representing investors and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in certain jurisdictions according to applicable laws and ethical guidelines.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
View original content to download multimedia: here
SOURCE The Schall Law Firm
Market News and Data brought to you by Benzinga APIs